Physician profile
Mohammad Hamshow
NPI 1720420763
$15,762.55
in general payments reported to CMS, 2019-2025
14 companies · $1,608 in 2025
The $1,608 reported for 2025 was more than what 79% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,423 · 2020: $78.36 · 2021: $30.21 · 2022: $1,655 · 2023: $98.10 · 2024: $4,870 · 2025: $1,608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,210 · Education: $2,000 · Food and Beverage: $1,367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,209.56 |
| Education | $2,000.00 |
| Food and Beverage | $1,367.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,428.93 | 2019-2025 | |
| Davol INC. | $1,324.10 | 2024-2025 | Phasix Mesh |
| Medical Device Business Services, INC. | $945.31 | 2019 | |
| Boston Scientific Corporation | $220.04 | 2020-2025 | Axios, Spyglass Discover |
| Ethicon US, LLC | $188.53 | 2019-2023 | Echelon; Endopath, Neuwave |
| Baxter Healthcare | $154.51 | 2023-2024 | Tisseel |
| Abbvie INC. | $104.34 | 2019 | |
| Olympus America INC. | $84.12 | 2019 | |
| Conmed Corporation | $83.33 | 2024 | Airseal |
| Teleflex LLC | $69.41 | 2020-2025 | Deknatel |
| Janssen Pharmaceuticals, INC | $54.07 | 2022 | |
| Integra Lifesciences Corporation | $43.68 | 2022 | |
| Polynovo North America LLC | $34.62 | 2024 | Novosorb Btm |
| Tela Bio, INC. | $27.56 | 2024 | Ovitex 2s |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Hamshow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.